Sansure Biotech Inc.
SSE:688289.SS
19.92 (CNY) • At close June 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 226.273 | 348.167 | 1,936.707 | 2,242.524 | 2,616.597 | 39.479 | 6.762 | -10.653 |
| Depreciation & Amortization
| 151.47 | 116.896 | 89.074 | 53.941 | 26.684 | 20.64 | 20.111 | 19.409 |
| Deferred Income Tax
| 0 | 0 | -39.952 | -8.066 | -4.646 | 0.664 | 3.885 | 13.283 |
| Stock Based Compensation
| 0 | 0 | 60.849 | 5.603 | 0 | 7.781 | 7.354 | 6.141 |
| Change In Working Capital
| -114.093 | -123.051 | 203.319 | -402.129 | -50.381 | -49.686 | -28.101 | -89.994 |
| Accounts Receivables
| 153.011 | 376.541 | -496.514 | -304.144 | -419.384 | -33.761 | -45.834 | -26.289 |
| Inventory
| 36.459 | -78.297 | -282.103 | -93.035 | -212.072 | -8.773 | -15.058 | -0.254 |
| Accounts Payables
| 0 | 0 | 496.514 | 3.116 | 585.722 | -7.816 | 28.906 | -76.733 |
| Other Working Capital
| -303.562 | -421.295 | 485.422 | -8.066 | -4.646 | 0.664 | -13.043 | -89.74 |
| Other Non Cash Items
| 10.798 | -229.191 | 308.95 | -14.803 | 49.377 | 3.529 | 11.295 | 19.793 |
| Operating Cash Flow
| 274.448 | 112.821 | 2,558.947 | 1,877.071 | 2,642.276 | 22.406 | 10.067 | -61.445 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -421.105 | -391.35 | -558.828 | -372.864 | -108.666 | -34.141 | -32.905 | -20.686 |
| Acquisitions Net
| -1.069 | 47.722 | -11.591 | 15.941 | 115.041 | 0.36 | 0.575 | 0.232 |
| Purchases Of Investments
| -1,167.125 | -7,434.262 | -12,140.55 | -7,879.952 | -3,725 | -195 | -100 | -0.9 |
| Sales Maturities Of Investments
| 1,545.404 | 9,225.65 | 11,591.092 | 7,125.563 | 2,111.334 | 130.94 | 100.738 | 0 |
| Other Investing Activites
| -58.027 | -49.97 | -46.869 | -0.909 | -108.666 | 3.242 | 109.108 | -44.16 |
| Investing Cash Flow
| -101.922 | 1,397.79 | -1,166.746 | -1,112.221 | -1,715.957 | -94.6 | 77.516 | -65.746 |
| Financing Activities: | ||||||||
| Debt Repayment
| 394.13 | 5 | 0 | -6.272 | 55 | 0 | 0 | -65.397 |
| Common Stock Issued
| 0 | 0 | 274.59 | 200.01 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -122.734 | -257.408 | -200.01 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -268.401 | -400.075 | -647.239 | -449.31 | -300 | 0 | 0 | -5.583 |
| Other Financing Activities
| 6.762 | -134.035 | -268.709 | -255.01 | 1,856.169 | 44.394 | 0 | 218.312 |
| Financing Cash Flow
| 132.491 | -529.11 | -915.948 | -688.591 | 1,609.901 | 44.394 | 0 | 147.331 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -0.003 | 0.345 | -10.008 | -34.253 | -44.586 | -0.046 | -0.105 | -0.131 |
| Net Change In Cash
| 305.014 | 1,072.564 | 466.244 | 42.006 | 2,491.634 | -27.847 | 87.478 | 20.009 |
| Cash At End Of Period
| 4,476.628 | 4,171.614 | 3,099.05 | 2,632.806 | 2,590.8 | 99.166 | 127.012 | 39.534 |